Strategies for subtypes—dealing with the diversity of breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2011
Authors
Discussion
Loading...
Member takes
Implication
Expert consensus guideline recommends subtype-directed systemic therapy in early breast cancer, highlighting tailored local and endocrine treatments.
Key Points
- Early breast cancer subtypes guide systemic treatment, where luminal A requires endocrine therapy while luminal B and HER2 positive cases warrant chemotherapy.
- Expert panel consensus establishes pragmatic classification approximating intrinsic biological subtypes through clinicopathological criteria rather than gene arrays.
- Highlights opportunities to de-escalate local treatments such as axillary dissection without losing efficacy, while balancing patient preferences and economic constraints.
Cite This Study
Goldhirsch et al. (2011) studied this question.